Importin α as a central regulator of nucleocytoplasmic transport: Structural basis, isoform diversification, and disease implications
Cellular Signalling · 2026-08 · 144 · 112558
DOI: 10.1016/j.cellsig.2026.112558 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-08. Verfasst von Yunlong Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Tiangong University, Tianjin 300387, China. Electronic address: liuyunlong@tiangong.edu.cn. Hauptthemen laut MEDLINE: alpha Karyopherins, Active Transport, Cell Nucleus, Cell Nucleus. Die Arbeit nennt 109 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Eukaryotic cellular homeostasis and function rely on efficient and specific nucleocytoplasmic transport, mediated by nuclear transport machinery. Importin α (Impα), a central adaptor protein in the classical nuclear import pathway, recognizes cargo proteins containing nuclear localization signals (NLSs) and facilitates their translocation into the nucleus. Structurally, this process involves interaction between the importin-β-binding (IBB) domain of Impα and importin β (Impβ), as well as recognition of cargo NLS motifs by major and minor NLS-binding sites formed by armadillo (ARM) repeat domains. The nuclear import function of Impα depends on coordinated spatial configuration and interactions among these conserved structural elements. Comparative structural analyses of Impα from representative organisms-including humans, mice, plants, and fungi-reveal conserved core functional modules with lineage-specific structural variations supporting functional adaptation across taxa. From a pathological perspective, Impα is implicated in multiple human diseases, with dysregulation often rooted in structural and molecular mechanisms. Many viruses exploit the conserved NLS recognition domain of Impα by encoding proteins that mimic host NLSs, hijacking the classical nuclear import pathway to enable viral nuclear entry and immune evasion. In cancer and other chronic diseases, aberrant expression or structural-functional impairment of Impα disrupts nucleocytoplasmic distribution of key signaling molecules and transcriptional regulators, driving disease progression. Given its structural characteristics and role in disease, Impα has emerged as a promising therapeutic target. A systematic understanding of Impα from structure to function and disease relevance provides a framework for developing therapeutic strategies to modulate nucleocytoplasmic transport pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Tiangong University, Tianjin 300387, China. Electronic address: liuyunlong@tiangong.edu.cn.
- School of Life Sciences, Tiangong University, Tianjin 300387, China.
- State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China. Electronic address: chenzhongzhou@cau.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Wang, Z., Wei, S., Yang, H., Ren, M., Fu, X., & Chen, Z. (2026). Importin α as a central regulator of nucleocytoplasmic transport: Structural basis, isoform diversification, and disease implications. Cellular Signalling, 144, 112558. https://doi.org/10.1016/j.cellsig.2026.112558
Vancouver
Liu Y, Wang Z, Wei S, Yang H, Ren M, Fu X, et al. Importin α as a central regulator of nucleocytoplasmic transport: Structural basis, isoform diversification, and disease implications. Cellular Signalling. 2026;144:112558. doi:10.1016/j.cellsig.2026.112558
BibTeX
@article{Liu2026,
author = {Liu, Yunlong and Wang, Ziheng and Wei, Shirong and Yang, Helian and Ren, Mengtian and Fu, Xiuping and Chen, Zhongzhou},
title = {Importin α as a central regulator of nucleocytoplasmic transport: Structural basis, isoform diversification, and disease implications},
journal = {Cellular Signalling},
year = {2026},
volume = {144},
pages = {112558},
doi = {10.1016/j.cellsig.2026.112558}
}
EUVIMED